108 related articles for article (PubMed ID: 30007567)
1. Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors.
Paudel S; Sun N; Khadka DB; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2018 Aug; 26(14):4127-4135. PubMed ID: 30007567
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.
Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2018 Nov; 26(20):5538-5546. PubMed ID: 30293797
[TBL] [Abstract][Full Text] [Related]
3. Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.
Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2017 Oct; 25(20):5278-5289. PubMed ID: 28807575
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors.
Paudel S; Acharya S; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2017 Apr; 25(7):2266-2276. PubMed ID: 28274674
[TBL] [Abstract][Full Text] [Related]
5. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE
J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
Paudel S; Cao Y; Guo S; An B; Kim KM; Cheon SH
Bioorg Med Chem; 2015 Oct; 23(19):6418-26. PubMed ID: 26337019
[TBL] [Abstract][Full Text] [Related]
7. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
[TBL] [Abstract][Full Text] [Related]
8. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
[TBL] [Abstract][Full Text] [Related]
9. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Shen F; Tsuruda PR; Smith JA; Obedencio GP; Martin WJ
PLoS One; 2013; 8(9):e74891. PubMed ID: 24098676
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.
Pontillo J; Wu D; Ching B; Hudson S; Genicot MJ; Gao Y; Ewing T; Fleck BA; Gogas K; Aparicio A; Wang H; Wen J; Wade WS
Bioorg Med Chem Lett; 2008 Dec; 18(23):6151-5. PubMed ID: 18954981
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.
Paudel S; Acharya S; Kim KM; Cheon SH
Bioorg Med Chem; 2016 May; 24(9):2137-45. PubMed ID: 27041397
[TBL] [Abstract][Full Text] [Related]
13. Structural exploration of (3S,6S)-6-benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine analogues: identification of potent triple monoamine reuptake inhibitors as potential antidepressants.
Santra S; Gogoi S; Gopishetty B; Antonio T; Zhen J; Reith ME; Dutta AK
ChemMedChem; 2012 Dec; 7(12):2093-100. PubMed ID: 23060293
[TBL] [Abstract][Full Text] [Related]
14. 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.
Vu AT; Cohn ST; Zhang P; Kim CY; Mahaney PE; Bray JA; Johnston GH; Koury EJ; Cosmi SA; Deecher DC; Smith VA; Harrison JE; Leventhal L; Whiteside GT; Kennedy JD; Trybulski EJ
J Med Chem; 2010 Mar; 53(5):2051-62. PubMed ID: 20131864
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.
Zhang P; Terefenko EA; McComas CC; Mahaney PE; Vu A; Trybulski E; Koury E; Johnston G; Bray J; Deecher D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6067-70. PubMed ID: 18951020
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and molecular docking study of piperazine derivatives as potent inhibitor of thymidine phosphorylase.
Uddin I; Taha M; Rahim F; Wadood A
Bioorg Chem; 2018 Aug; 78():324-331. PubMed ID: 29626638
[TBL] [Abstract][Full Text] [Related]
17. Vinylogous amide analogs of methylphenidate.
Froimowitz M; Gu Y; Dakin LA; Kelley CJ; Parrish D; Deschamps JR
Bioorg Med Chem Lett; 2005 Jun; 15(12):3044-7. PubMed ID: 15908207
[TBL] [Abstract][Full Text] [Related]
18. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
[TBL] [Abstract][Full Text] [Related]
19. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.
McComas CC; Vu AT; Mahaney PE; Cohn ST; Fensome A; Marella MA; Nogle L; Trybulski EJ; Ye F; Zhang P; Alfinito P; Bray J; Johnston G; Koury E; Deecher DC
Bioorg Med Chem Lett; 2008 Sep; 18(18):4929-31. PubMed ID: 18771916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
